SanBio Company Limited
SNBIF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $49,685 | $38,374 | $41,430 | $56,052 |
| - Cash | $2,921 | $4,455 | $6,733 | $4,557 |
| + Debt | $397 | $665 | $933 | $2,525 |
| Enterprise Value | $47,161 | $34,584 | $35,631 | $54,020 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$15 | -$25 | -$132 |
| % Margin | – | – | – | – |
| EBITDA | -$3,507 | -$4,525 | -$4,649 | -$4,383 |
| % Margin | – | – | – | – |
| Net Income | -$2,882 | -$2,644 | -$5,560 | -$4,678 |
| % Margin | – | – | – | – |
| EPS Diluted | -41.85 | -40.48 | -95.99 | -90.33 |
| % Growth | -3.4% | 57.8% | -6.3% | – |
| Operating Cash Flow | -$3,603 | -$4,766 | -$7,434 | -$6,547 |
| Capital Expenditures | -$5 | -$55 | -$8 | -$56 |
| Free Cash Flow | -$3,608 | -$4,821 | -$7,442 | -$6,603 |